Ingrid Winship

Ingrid Winship, MBBS, MD, FRACP, FRCPA is Professor of Adult Clinical Genetics and Head of Genomic Medicine at the University of Melbourne and Royal Melbourne Hospital. She is a leading international authority on hereditary cancer syndromes, polygenic risk scoring (PRS) for cancer prevention, and the translation of population-level cancer genomics into clinical practice. Winship has been central to the Australian Genomics Health Alliance (AGHA) and has led population-based programs demonstrating the real-world utility of polygenic risk scores for stratifying breast, colorectal, and prostate cancer risk in clinical settings. Her work integrates germline pathogenic variant testing with polygenic risk scoring to create comprehensive cancer risk profiles for prevention counseling, demonstrating that PRS adds meaningful discrimination to monogenic risk models. She has also been a leader in evaluating real-world evidence for biomarker-driven hereditary cancer screening programs, including universal Lynch syndrome testing in colorectal cancer. Winship serves on multiple Australian and international genomic medicine guideline committees and has published over 250 peer-reviewed articles.